Sign in →

Test Code LAB2123 Toxoplasma gondii, Molecular Detection, PCR, Varies

Useful For

Supporting the diagnosis of acute cerebral, ocular, disseminated, or congenital toxoplasmosis

 

This test should not be used to screen healthy patients.

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Specimen Type

Varies


Necessary Information


Specimen source is required.



Specimen Required


Submit only 1 of the following specimens:

 

Specimen Type: Amniotic fluid

Container/Tube: Sterile container

Specimen Volume: 0.5 mL

Collection Instructions: Do not centrifuge.

 

Specimen Type: Spinal fluid

Supplies: Sarstedt Aliquot Tube 5 mL (T914)

Container/Tube:

Preferred: 12 x 75-mm screw cap vial

Acceptable: Sterile vial

Specimen Volume: 0.5 mL

Collection Instructions: Do not centrifuge.

 

Specimen Type: Fresh tissue

Supplies:M4-RT (T605)

Container/Tube:

Preferred: Multi-microbe medium (eg, M4-RT)

Acceptable: Sterile container with 1 to 2 mL of sterile saline

Specimen Volume: Entire collection

Collection Instructions: Submit only fresh tissue in a sterile container containing 1 mL to 2 mL of sterile saline or multi-microbe medium (M4-RT, M4, or M5)

 

Specimen Type: Ocular fluid

Supplies: Sarstedt Aliquot Tube 5 mL (T914)

Collection Container: 12 x 75-mm screw cap vial

Specimen Volume: 0.3 mL

Collection Instructions:

1. Aliquot collected fluid into screw-cap vial. Do not submit ocular fluid in syringe.

2. Do not centrifuge or dilute the specimen.


Specimen Minimum Volume

Amniotic Fluid, Ocular Fluid, Spinal Fluid: 0.3 mL
Tissue: 2 × 2 mm biopsy

Specimen Stability Information

Specimen Type Temperature Time Special Container
Varies Refrigerated (preferred) 7 days
  Frozen  7 days

Reference Values

Negative

Day(s) Performed

Monday through Saturday

CPT Code Information

87798

LOINC Code Information

Test ID Test Order Name Order LOINC Value
PTOX Toxoplasma gondii PCR 29904-0

 

Result ID Test Result Name Result LOINC Value
SRC74 Specimen Source 31208-2
81795 Toxoplasma gondii PCR 29904-0

Interpretation

A positive result indicates presence of DNA from Toxoplasma gondii.

 

Negative results indicate absence of detectable DNA but do not exclude the presence of organism or active or recent disease.

Method Description

DNA from clinical specimens is extracted using the Roche MagNA Pure system. Toxoplasma gondii DNA is then detected by using real-time polymerase chain reaction (PCR) to amplify the target sequence. The LightCycler amplifies and monitors fluorescent development of target nucleic acid after each cycle. The continuous monitoring is derived from the fluorescence resonance energy transfer (FRET) principle: a hybridization probe with a donor fluorophore on the 3' end is excited by an external light source and emits light that is absorbed by a second hybridization probe with an acceptor fluorophore at the 5' end. The acceptor fluorophore emits light of a different wavelength that can be measured with a signal that is proportional to the amount of specific PCR product. Melting temperature analysis is used following amplification for sensitive and specific detection of amplified target DNA.(Cockerill FR, Uhl FR. Applications and challenges of real-time PCR for the clinical microbiology laboratory. In: Reischl U, Wittwer C, Cockerill F, eds. Rapid Cycle Real-Time PCR, 2002; Nolte FS. Target amplification techniques. In Carroll KC, Pfaller MA, Landry ML, et al, eds. Manual of Clinical Microbiology. 12th ed. ASM Press; 2019)

Report Available

Same day/1 to 4 days

Specimen Retention Time

7 days

Reject Due To

Heat-inactivated specimen Reject

Method Name

Polymerase Chain Reaction (PCR)/DNA Probe Hybridization

Forms

If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.

Testing Algorithm

For more information see Meningitis/Encephalitis Panel Algorithm

Secondary ID

81795